T. Scott Stroup, MD

  • 9Articles
  • 34.9KReads
  • 2007–2024Active
  • 58Collaborators
  • 301Citations

About

T. Scott Stroup, MD, is affiliated with the New York State Psychiatric Institute and the Department of Psychiatry at Columbia University Vagelos College of Physicians & Surgeons in New York. His work, published between 2007 and 2024 in Psychiatrist.com, focuses on schizophrenia, schizoaffective disorders, depression, and neurology. He has frequently collaborated with Joseph P. McEvoy, Del D. Miller, Robert A. Rosenheck, Marvin S. Swartz, and Nina R. Schooler.

Publications

JCP
Brief Video Intervention to Reduce Self-Stigma of Mental Illness
Original Research

Brief Video Intervention to Reduce Self-Stigma of Mental Illness

March 6, 2024

A 2-minute social contact–based video intervention decreased self-stigma in young people with ongoing mental health conditions.
, , , et al
JCP
Original Research

Heterogeneity of Treatment Effects of LAI Antipsychotics

November 27, 2018

Which subgroups of patients with schizophrenia or schizoaffective disorder may be prone to treatment failure? Is it men or women, old or young, or are more factors involved? Researchers...
, , , et al
JCP
Original Research

Antipsychotic Medications in Adult Depression

July 5, 2017

Antipsychotic medications are increasingly prescribed to treat depression. But is this use always warranted? Read the article by Gerhard and colleagues to learn how often antipsychotics are prescribed in...
, , , et al
JCP
Commentary

What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?

November 24, 2014

JCP
Original Research

Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial

May 15, 2012

, , , et al
JCP
Article

Minimum Clinically Important Difference in the Positive and Negative Syndrome Scale With Data From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

April 15, 2012

, , , et al
JCP
Original Research

Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres: An Open-Label, Randomized Controlled Trial

March 6, 2012

, , , et al
JCP
Original Research

Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia

August 10, 2010

, , , et al
JCP
Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2006 Update

November 15, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe